Remimazolam Bolus for General Anesthesia

Loss of Consciousness Clinical Trial

Official title:
ED50 and ED95 of Remimazolam Intravenous Bolus on the Loss of Consciousness in Patients Undergoing General Anesthesia

Status Completed

Clinical Trial Summary

It is important to estimate the adequate dose of remimazolam intravenous bolus injection to induce the loss of consciousness. We will determine the ED50 and ED95 of remimazolam intravenous bolus on the loss of consciousness in patients undergoing general anesthesia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04901871
Study type	Interventional
Source	Gangnam Severance Hospital
Contact
Status	Completed
Phase	Phase 3
Start date	May 27, 2021
Completion date	July 26, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04502550` - Brain Networks and Consciousness
Completed	`NCT02783846` - The Effects of Different Doses of Dexmedetomidine on Propofol Requirement for Loss of Consciousness Undergoing Bispectral Index: a Double-blinded, Placebo-controlled Trial	N/A
Completed	`NCT02125214` - Alteration of Temporal Organization of EEG Microstate Sequences During Propofol-induced Loss of Consciousness	N/A
Completed	`NCT02831101` - Sufentanil Bispectral Index Elderly	N/A
Terminated	`NCT00143754` - Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope	Phase 3